Trexquant Investment’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Trexquant Investment’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,258	Closed	-$285K	–	1509
2017 Q4	$285K	Buy	+2,258	New	+$289K	0.03%	776
2017 Q3	–	Sell	-1,095	Closed	-$156K	–	1138
2017 Q2	$156K	Sell	1,095 -348	-24%	-$53.8K	0.04%	709
2017 Q1	$265K	Buy	+1,443	New	+$162K	0.03%	820
2015 Q2	–	Sell	-1,405	Closed	-$1.03M	–	1342
2015 Q1	$1.03M	Buy	+1,405	New	+$1.06M	0.11%	352

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Trexquant Investment's TTPH Position: Q1 2018 in Review

Trexquant Investment sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2018, closing a stake of 2,258 shares — an estimated $285K sold.

Trexquant Investment first reported a position in TTPH in Q1 2015 and held it in 4 quarters. The position peaked at $1.03M in Q1 2015. 94 funds tracked by Wall St. Rank hold TTPH as of Q1 2018.

Trexquant Investment reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Trexquant Investment sold 2,258 Tetraphase Pharmaceuticals, Inc. shares in Q1 2018, an estimated $285K.
Trexquant Investment first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
Trexquant Investment's Tetraphase Pharmaceuticals, Inc. position peaked at $1.03M in Q1 2015.
94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.